CORRESP Filing
ARTELO BIOSCIENCES, INC.
Date: March 20, 2026 · CIK: 0001621221 · Accession: 0001640334-26-000508
AI Filing Summary & Sentiment
File numbers found in text: 333-294506
Show Raw Text
CORRESP 1 filename1.htm artl_corresp.htm March 20, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, DC 20549 Attn: Doris Stacey Gama Re: Artelo Biosciences, Inc. Registration Statement on Form S-1 (File No. 333-294506) — Concurrence in Acceleration Request Ladies and Gentlemen: Craft Capital Management LLC (“ Craft Capital ”), solely acting as placement agent on a best-efforts basis in an offering pursuant to the Registration Statement on Form S-1 (File No. 333-294506) (the “ Registration Statement ”) filed by Artelo Biosciences, Inc. (the “ Company ”), hereby concurs in the request by the Company that the effective date of the above-referenced Registration Statement be accelerated to 5:00 p.m. Eastern Time on Tuesday, March 24, 2026, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act of 1933, as amended. Craft Capital affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement. Very truly yours, CRAFT CAPITAL MANAGEMENT LLC By: /s/ Mackey McFarlane Name: Mackey McFarlane Title: Head of Investment Banking cc: Morris Zarif, Esq., Zarif Law Group P.C.